We are live on
!
Find out more
IB
Intrust Bank Portfolio holdings
AUM
$1.35B
Turnover
12.1%
1-Year Est. Return
37.16%
This Fund
S&P 500
This Quarter
Est. Return
-14.49%
1 Year Est. Return
+37.16%
3 Year Est. Return
+102.36%
5 Year Est. Return
+128.73%
10 Year Est. Return
+460.32%
AUM
$692M
AUM Growth
-$98.5M
(-12%)
Cap. Flow
+$27.7M
Cap. Flow
% of AUM
4%
Top 10 Holdings %
Top 10 Hldgs %
39.83%
Holding
410
New
29
Increased
158
Reduced
183
Closed
27
Avg Time Held
4.5
years
Top 10 Avg Time Held
2.9
years
Top 20 Avg Time Held
3.2
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P Mid-Cap ETF
IJH
|
+$23M |
| 2 |
Vanguard Morningstar Mid-Cap ETF
VO
|
+$9.89M |
| 3 |
Vanguard FTSE Developed Markets ETF
VEA
|
+$5.22M |
| 4 |
Vanguard Morningstar Large-Cap ETF
VV
|
+$3.96M |
| 5 |
JPMorgan US Momentum Factor ETF
JMOM
|
+$1.92M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core MSCI EAFE ETF
IEFA
|
+$4.82M |
| 2 |
Vanguard S&P 500 ETF
VOO
|
+$4.6M |
| 3 |
iShares MSCI EAFE ETF
EFA
|
+$2.18M |
| 4 |
Apple
AAPL
|
+$1.97M |
| 5 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.24M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 40.54% |
| 2 | Technology | 12.77% |
| 3 | Healthcare | 10.62% |
| 4 | Financials | 7.83% |
| 5 | Industrials | 6.17% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
151
Unilever
UL
$140B
| $834K | 0.12% |
16,173
+7,847
| +94% | +$400K |
2013 Q2
36 quarters
|
|
152
Capital One
COF
$121B
| $821K | 0.12% |
7,873
+158
| +2% | +$19.3K |
2013 Q2
36 quarters
|
|
153
AstraZeneca
AZN
$260B
| $814K | 0.12% |
6,158
+310
| +5% | +$40.7K |
2021 Q1
5 quarters
|
|
154
Chesapeake Utilities
CPK
$3.31B
| $812K | 0.12% |
6,270
+89
| +1% | +$11.6K |
2016 Q2
24 quarters
|
|
155
DELISTED
Discover Financial Services
DFS
| $811K | 0.12% |
8,571
-160
| -2% | -$17.1K |
2013 Q2
36 quarters
|
|
|
JMIN
156
DELISTED
JPMorgan U.S. Minimum Volatility ETF
JMIN
| $800K | 0.12% |
22,593
+12,712
| +129% | +$471K |
2021 Q1
5 quarters
|
|
157
Cigna
CI
$79B
| $799K | 0.12% |
3,034
+524
| +21% | +$135K |
2019 Q4
10 quarters
|
|
158
DELISTED
Pioneer Natural Resource Co.
PXD
| $794K | 0.11% |
3,557
-179
| -5% | -$45.4K |
2017 Q4
18 quarters
|
|
159
Ford
F
$48.7B
| $790K | 0.11% |
71,022
+3,970
| +6% | +$54.4K |
2014 Q1
33 quarters
|
|
160
Sony
SONY
$145B
| $786K | 0.11% |
48,045
+4,765
| +11% | +$84.4K |
2014 Q1
33 quarters
|
|
161
Constellation Brands
STZ
$21.9B
| $779K | 0.11% |
3,342
+364
| +12% | +$88.6K |
2016 Q1
25 quarters
|
|
162
Intercontinental Exchange
ICE
$88.6B
| $772K | 0.11% |
8,217
-2,038
| -20% | -$218K |
2016 Q4
22 quarters
|
|
163
Enbridge
ENB
$104B
| $770K | 0.11% |
18,210
+1,466
| +9% | +$65.4K |
2020 Q3
7 quarters
|
|
164
Vodafone
VOD
$36.6B
| $767K | 0.11% |
49,193
+6,528
| +15% | +$104K |
2020 Q3
7 quarters
|
|
165
NXP Semiconductors
NXPI
$57.5B
| $764K | 0.11% |
5,164
+512
| +11% | +$89K |
2019 Q1
13 quarters
|
|
166
Cooper Companies
COO
$10.8B
| $763K | 0.11% |
9,756
-1,708
| -15% | -$151K |
2016 Q2
24 quarters
|
|
167
CBRE Group
CBRE
$38.8B
| $759K | 0.11% |
10,321
-375
| -4% | -$30.2K |
2016 Q1
25 quarters
|
|
168
McCormick & Company Non-Voting
MKC
$12.4B
| $747K | 0.11% |
8,973
-1,134
| -11% | -$107K |
2017 Q3
19 quarters
|
|
169
Regeneron Pharmaceuticals
REGN
$82.9B
| $741K | 0.11% |
1,253
+14
| +1% | +$9.1K |
2020 Q3
7 quarters
|
|
170
Sanofi
SNY
$96.5B
| $735K | 0.11% |
14,696
+2,240
| +18% | +$119K |
2020 Q1
9 quarters
|
|
171
Ulta Beauty
ULTA
$25.7B
| $735K | 0.11% |
1,907
+184
| +11% | +$73.1K |
2015 Q2
28 quarters
|
|
172
BCE
BCE
$19B
| $721K | 0.1% |
14,651
+986
| +7% | +$52.9K |
2013 Q2
36 quarters
|
|
173
Danaher
DHR
$162B
| $713K | 0.1% |
3,172
+463
| +17% | +$107K |
2020 Q3
7 quarters
|
|
174
Copart
CPRT
$25.6B
| $712K | 0.1% |
26,200
-9,468
| -27% | -$270K |
2018 Q2
16 quarters
|
|
175
Crown Castle
CCI
$34.4B
| $709K | 0.1% |
4,213
-131
| -3% | -$23.8K |
2021 Q1
5 quarters
|
|
Similar funds
CC
HVCM
RI
RCYC
KB
NC
PP
OPFM
Intrust Bank's Q2 2022 Portfolio in Review
As of Q2 2022, Intrust Bank held 410 positions worth $692M, down 12% from $790M the previous quarter. Its ten largest holdings account for 40% of the portfolio.
Intrust Bank deployed $27.7M of net new capital in Q2 2022, opening 29 new positions and adding to 158 existing holdings. Its largest new stake was iShares Core S&P Mid-Cap ETF: 465,760 shares worth $21.1M.
By sector, the portfolio is most concentrated in Miscellaneous at 41% of assets, up from 37% a quarter earlier, followed by Technology and Healthcare.
On the sell side, the largest reduction was iShares Core MSCI EAFE ETF, an estimated $4.82M trimmed.
- Intrust Bank's largest Q2 2022 buy was iShares Core S&P Mid-Cap ETF: 465,760 shares worth $21.1M.
- Intrust Bank added most to Vanguard FTSE Developed Markets ETF in Q2 2022, an estimated $5.22M increase.
- Intrust Bank's biggest Q2 2022 reduction was iShares Core MSCI EAFE ETF, cutting an estimated $4.82M.
- Intrust Bank fully exited Akamai in Q2 2022, selling an estimated $585K.
- Intrust Bank's ten largest holdings make up 40% of its $692M portfolio in Q2 2022.
- Intrust Bank opened 29 new positions and closed 27 in Q2 2022.
- Intrust Bank's portfolio value fell 12% quarter-over-quarter to $692M.
Based on Intrust Bank's 13F filing for Q2 2022, filed 16 Aug 2022.